Introduction
Th e lack of standardized methods for human phenotyping is a major obstacle to translational science. Th e benefi ts of carefully collecting and organizing phenotypic information for research purposes are exemplifi ed by the Framingham study, which has directly infl uenced medical practice and led to improvements in human health. 1 Advances in genomics and proteomics off er extraordinary opportunities for translational research. However, their successful application requires correlation with high-quality phenotypic information, especially with regard to subtle and/or complex gene-gene and gene-environment interactions. 2 Yet phenotyping as a scientifi c discipline has not kept pace with advances in genetics, prompting Freimer and Sabatti to call for a "human phenome project. " 3 Rockefeller University investigators have therefore undertaken an initiative to enhance human phenotyping under the auspices of a Clinical and Translational Science Award (CTSA). To address the defi ciencies in current practices-including the lack of standardized, rigorous, and comprehensive data recording instruments, the common practice of discarding case report forms aft er study completion, and the use of diff erent instruments by diff erent investigators-we developed an electronic phenotyping system that could be used by investigators worldwide. Th is prototype system uses the bleeding history as a paradigm.
In order to promote standardization, collaboration, transparency, and aggregation of data from multiple sources, the bleeding history phenotyping system was grounded in the creation of a domain ontology. Ontologies help to achieve these goals by explicitly defi ning the existing knowledge about the disorder and formally encoding that information. In this way, the ontology helps a community of investigators develop a common understanding of the disorder, and in the process makes assumptions about the disorder explicit. Th e ontology's structure facilitates the organization, retrieval, and analysis of the encoded knowledge, including database design and merging of databases. Examples of valuable ontologies include the gene ontology (GO), 4 which organizes rapidly expanding genetic data, and the Internet search engine Yahoo.
In addition, we set the following goals for the system: (1) ensure the quality of the instrument by expert review (2) maximize the use of standardized vocabulary for medical terms (3) ensure the security of the system (4) ensure transparency by making the instrument publicly available (5) facilitate adoption of the recording instrument by investigators at other sites by making it Web-accessible, and (6) connect the instrument to a scalable database. To achieve these goals, in addition to the bleeding history ontology (BHO), we developed a comprehensive bleeding history questionnaire (BHQ), an electronic phenotype recording instrument (PRI), and a database. Together, these comprise the bleeding history phenotyping system (BHPS) (Figure 1 ).
Methods

Bleeding history questionnaire
Th e BHPS was based on a comprehensive questionnaire (the BHQ), which in turn was derived from a paper-based reminder form developed by one of the authors for clinical use. 5 To ensure that it was comprehensive, this original document was dramatically expanded based on an extensive literature review 5 and comments from expert hematologists. Th e questionnaire was formatted to include both yes/no and multiple choice questions, and to allow for the entry of data on multiple episodes of bleeding in the same category (e.g., surgery). A comprehensive list of treatments was also developed for select questions. Th e question format in the BHQ was reviewed by an expert in questionnaire development. To standardize the language used in the questionnaire (and subsequently, the ontology), 168 terms were mapped to Unifi ed Medical Language System (UMLS) codes.
We chose an intermediate level of formality to strike a balance between intuitiveness and facilitation of computer processing. Th e BHQ defi ned the scope of the ontology and it was constructed using Protégé, 10 an open-source ontology editor supported by the National Center for Biomedical Ontology (NCBO, http:// www.bioontology.org/). Aft er completion, the BHO was made publicly available on BioPortal (http://bioportal.bioontology. org/visualize/38563) to allow others to comment on it and off er suggestions for improvement and updating.
Th e ontology was initially developed in Protégé Frames, then later converted to the Web Ontology Language (OWL 11 ) format in order to meet Semantic Web standards. It consists of Classes (i.e., concepts), Individuals within Classes (i.e., concrete entities of the concepts), and Properties (definitions of the interrelationship between and among Classes and, by defi nition, the interrelationship of their Individuals).
Th e ontology comprises two "subontologies:" a bleeding history application ontology (BHAO) and a bleeding history domain ontology (BHDO) (Figure 2 ). An application ontology represents a specifi c application, for example the questions used in the BHQ. In contrast, a domain ontology organizes information on a subject independent of how one might acquire or use the information. 9 Th us, the BHAO captures the exact phrasing and format of the BHQ, whereas the BHDO is a generic ontology that defi nes an idealized conceptualization of the bleeding history, independent of the specifi c questions asked to elicit the information.
To create the BHAO, question categories were used to defi ne Classes, and the wording of individual questions was entered into Protégé under those Classes. To create the BHDO, medical terms used in the questionnaire were organized into idealized, hierarchically structured Classes. Th ese generic Classes were designed to be similar in content to the questionnaire but independent of specifi c question syntax. To link the BHAO to the BHDO, shared Properties were defi ned. Th ese Properties connect Classes from the two ontologies to one another.
Combinations of Classes and Properties defi ne Individuals. As used in the context of an ontology, the term Individual does not refer to a unique person, but rather a specifi c question response or bleeding episode. For instance, in the example depicted in Figure 2 , information about an episode of epistaxis is collected via questions from the BHAO Class "Epistaxis. " One question within this Class is described by the Property "FrequencyOf." Th e combination of the BHAO Class "Epistaxis" and BHAO Property "FrequencyOf " defi nes an Individual, i.e., a specifi c episode of epistaxis. Th e same Property links that BHAO Individual to the BHDO Class "Epistaxis, " defi ning the same episode in generic terms. Th is organization separates the specifi c questionnaire syntax from generic knowledge, a useful property that can be leveraged to support a variety of applications, including database mergers. Th e latter may be vital in aggregating legacy data with data obtained prospectively with newer instruments. Creation of the bleeding history phenotyping system. After an extensive literature search and review by experts, a paper-based bleeding history clinical reminder form was expanded into a comprehensive bleeding history questionnaire (BHQ). The questionnaire was used to derive a bleeding history ontology (BHO) as well as a bleeding history database and a graphical user interface and electronic recording instrument, the phenotype recording instrument (PRI).
Figure 2. Conceptual schematic of the bleeding history application ontology and bleeding history domain ontology.
The examples of epistaxis and two associated questions are depicted. By deriving its structure directly from the bleeding history questionnaire, the bleeding history application ontology captures exact question syntax. In contrast, the bleeding history domain ontology is an idealized conceptualization of bleeding events, divorced from the exact syntax of any particular question. The bleeding history application ontology is linked to the bleeding history domain ontology via shared Properties. These Properties, in combination with Classes from either ontology, defi ne Individuals, which is a technical term that should not be confused with a specifi c person.
Database
A MySQL database was generated from the fi nished ontology. 12 First, the ontology structure was exported to an Extensive Markup Language (XML) fi le. A parsing program was used to convert this XML fi le to a Structured Query Language (SQL) statement containing the structures of questions and answers represented in the ontology. Th ese SQL statements were entered into MySQL to populate table structures and defi ne tabular relationships. Because this process produced a database congruent with the ontology, the database can be easily updated as knowledge about bleeding phenotypes (and therefore the bleeding history ontology) evolves. Th e database was made Web-accessible and housed on a Rockefeller University server behind an institutional fi rewall to ensure security. Th is organization permits investigators worldwide to contribute and query their de-identifi ed data.
Phenotype recording instrument
To facilitate the entry and retrieval of data by investigators, we created a separate Web-based PRI using Python and the Django Web Application Framework 13 ( Figure 3) . Access to the PRI requires a password and identifi cation of the site and protocol. Data are entered via a system-generated unique personal identifi cation number (UPIN) rather than by name or other personal identifi er. Th e individual's age, rather than date of birth, is obtained to further minimize the risk of identifi cation. Genealogic information, which poses a theoretical risk of personal identifi cation, is obtained because it is vital to the scientifi c and clinical goals of the project. A timestamp is incorporated into the PRI to permit analysis of the time required to complete the study. Subjects can log in and out at their convenience without data loss. Visual aids such as high-quality photographs are included to help individuals understand the questions and ensure standardization. Within the PRI, each group of phenotypic symptoms is independently accessible so as to create convenient, modular questionnaire sections. Within sections, logical axioms are implemented to speed questionnaire completion. For instance, a research subject answering "Yes" to the question "Have you ever had or do you currently have spontaneous nosebleeds?" would be directed to appropriate follow-up questions (Figure 2) . In contrast, a subject answering "No" would not be asked any of the 14 additional questions about nosebleeds and instead would be directed to the next question module. Th ese axioms allowed the BHQ to be completed in a median time of 30 minutes in the fi rst study conducted with 500 healthy individuals.
14 Data representation and query utilities are included to help investigators retrieve and review their data. Th ese permit investigators to query the database for questionnaire responses and generate printable pdf fi les containing individual responses or graphical representations of data collated from the responses of multiple individuals. One goal of this project is to encourage individual investigators to add the de-identifi ed data from their studies into a common data repository that will benefi t from the increase in sample size. Investigators who elect to participate in creating the aggregated database will be granted authority to query the entire database, fi lter the query by subject characteristics (such as bleeding disorder diagnoses), and generate a downloadable spreadsheet that is suitable for statistical analyses.
Discussion
The BHPS offers investigators with Internet access a comprehensive and standardized format for collecting, storing, and retrieving bleeding phenotypes. Use of this system will permit investigators to collect and compare data across diff erent institutions and studies. In addition, it will facilitate data aggregation from a large number of subjects, which is necessary for detailed genotype-phenotype-environment correlations. Th e ontology on which the system is built not only provides an eff ective tool to organize and analyze data, but also provides a transparent mechanism for the hemostasis community to continually update its understanding of the relationships among and between bleeding signs and symptoms, bleeding disorders, laboratory data, and therapies.
The many potential applications for this system include: defi ning the range of bleeding symptoms in normal populations; defi ning patterns of bleeding symptoms in diff erent disorders; optimizing diagnostic criteria for diff erentiating normals from individuals with bleeding disorders developing streamlined sets of questions to assess the likelihood of bleeding from invasive procedures or treatment with anticoagulants or antiplatelet agents; assessing whether to initiate laboratory evaluations; correlating bleeding symptoms with biochemical, genetic, proteomic, and other data; and identifying patients with discordances between bleeding symptoms and biochemical data for further analysis of genetic and environmental infl uences. We have begun our own studies by analyzing the bleeding symptoms of 500 normal individuals of diff erent ages, sexes, races, and ethnic groups. We plan to also publicly share these data when completed to help other investigators establish the normal ranges in their populations. 14 We especially hope that the ready availability of the BHPS and the normal control data will encourage and help junior investigators to begin careers in studying bleeding disorders. We anticipate that the approach we have taken may be applicable to a number of other disorders and we have prepared materials to help others create their own phenotyping systems for these disorders.
